 Connection
Emily Parker to Follow-Up Studies
This is a "connection" page, showing publications Emily Parker has written about Follow-Up Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.103 |
|
|
|
-
Parker ED, Margolis KL, Trower NK, Magid DJ, Tavel HM, Shetterly SM, Ho PM, Swain BE, O'Connor PJ. Comparative effectiveness of 2 ß-blockers in hypertensive patients. Arch Intern Med. 2012 Oct 08; 172(18):1406-12.
Score: 0.051
-
Fortuna LA, Pawloski PA, Parker ED, Trower NK, Kottke TE. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events. Eur Heart J Cardiovasc Pharmacother. 2016 01; 2(1):13-9.
Score: 0.016
-
Kharbanda EO, Parker ED, Sinaiko AR, Daley MF, Margolis KL, Becker M, Sherwood NE, Magid DJ, O'Connor PJ. Initiation of oral contraceptives and changes in blood pressure and body mass index in healthy adolescents. J Pediatr. 2014 Nov; 165(5):1029-33.
Score: 0.015
-
Nordin JD, Parker ED, Vazquez-Benitez G, Kharbanda EO, Naleway A, Marcy SM, Molitor B, Kuckler L, Baggs J. Safety of the yellow Fever vaccine: a retrospective study. J Travel Med. 2013 Nov-Dec; 20(6):368-73.
Score: 0.014
-
Folsom AR, Parker ED, Harnack LJ. Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease. Am J Hypertens. 2007 Mar; 20(3):225-32.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|